Comparative efficacy of carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) in newly‐diagnosed multiple myeloma: A systematic review and meta‐analysis
Journal article published in 2024 by
Bruno Almeida Costa 
,
Thomaz Alexandre Costa ,
Kevin Pak ,
Aesha Patel ,
Nicole Felix ,
Tarek H. Mouhieddine ,
Joshua Richter
,
Thomaz Alexandre Costa ,
Kevin Pak ,
Aesha Patel ,
Nicole Felix ,
Tarek H. Mouhieddine ,
Joshua Richter
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 